Sepassi A, Saunders IM, Bounthavong M, Taplitz RA, Logan C, Watanabe JH. Effectiveness of letermovir for cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplant recipients: A global systematic review. J Am Pharm Assoc. 2023. (Link)
Sepassi A, Saunders IM, Bounthavong M, Taplitz RA, Logan C, Watanabe JH. Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared with Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United States. Pharmacoecon Open. 2023. (Link)
Sepassi A, Garcia S, Tanjasiri S, Lee S, Bounthavong M. Predicted Health Literacy Disparities Between Immigrant and US-Born Racial/Ethnic Minorities: A Nationwide Study. J Gen Intern Med. 2023. (Link)
Sepassi A, Saunders IM, Bounthavong M, Taplitz RA, Logan C, Watanabe JH. Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared to Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United States. Pharmacoecon Open. 2023. (Link)
Chan K, Sepassi A, Saunders IM, Goodman A, Watanabe JH. Effects of financial toxicity on prescription drug use and mental well-being in cancer patients. Explor Res Clin Soc Pharm. 2022;6:100136. (Link)
Sepassi A, Bounthavong M, Singh RF, Heyman M, Beizai K, Watanabe JH. Risk of Negative Health Outcomes and High Costs for People with Diabetes and Unmet Psychological Needs in the United States. Diabetes Spectr. 2022;35(2):207-215. (Link)
Bounthavong M, Suh K, Li M, Spoutz PM, Stottlemyer BA, Sepassi A. Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017. Subst Abuse Treat Prev Policy. 2021;16(1):80. (Link)
Puzniak L, Finelli L, Yu KC, Bauer KA, Moise P, De Anda C, Vankeepuram L, Sepassi A, Gupta V. A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19. BMC Infect Dis. 2021;21(1):227. (Link)
Sepassi A, Watanabe JH. Emergency Department Visits for Psychotropic-Related Adverse Drug Events in Older Adults with Alzheimer’s Disease, 2013-2014. Ann Pharmacother. 2019;53(12):1173-1183. (Link)
Sepassi A, Chingcuanco F, Gordon R, Meier A, Divino V, DeKoven M, Ben-Joseph R. Resource utilization and charges of patients with and without diagnosed venous thromboembolism during primary hospitalization and after elective inpatient surgery: a retrospective study. J Med Econ. 2018;21(6):595-602. (Link)